Value of bone scanning in the follow-up of breast cancer patients : a study of 1000 cases von SCHUÊNEMANN, H, LANGECKER, P. J, ELLGAS, W, LEONHARDT, A, MERKL, H

Volltext

The effects of atamestane, toremifene, and atamestane plus toremifene compared to letrozole on bone, serum lipids and uterus von Goss, P. E., Qi, S., Hu, H., Cheung, A. M., Lang, W., Blanchett, D. G., Langecker, P. J.

Volltext

Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses von Buckwold, Victor E., Wei, Jiayi, Huang, Zhuhui, Huang, Chunsheng, Nalca, Aysegul, Wells, Jay, Russell, Julie, Collins, Barbara, Ptak, Roger, Lang, William, Scribner, Curtis, Blanchett, Dennis, Alessi, Tom, Langecker, Peter

Volltext

(273) Clinical trial results: A randomized, double-blind, placebo controlled, trial of three-day bupivacaine transdermal patch (ELADUR) in patients with post-herpetic neuralgia von Wallace, M, Kudrow, D, McElveen, W, Drass, M, Webster, L, Huddlestone, J, Reynolds, L, Lissin, D, Langecker, P

Volltext

[11] PHASE 2 STUDY OF OMEGA INTERFERON ALONE OR IN COMBINATION WITH RIBAVIRIN IN SUBJECTS WITH CHRONIC HEPATITIS C GENOTYPE-1 INFECTION von Novozhenov, V, Zakharova, N, Vinogradova, E, Nikitin, I, Gorbakov, V, Yakovlev, A, Pak, S, Rafalski, V, Bogomolov, P, Alessi, T, Blanche, D, Lang, W, Langecker, P, McNally, J, McHutchison, J

Volltext

Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer von SCHRIJVERS, D, JOHNSON, J, RIVIERE, A, ARVAY, C, LANGECKER, P, JACOB, H, CVITKOVIC, E, VOKES, E, JIMINEZ, U, GORE, M, KOSMIDIS, P, SZPIRGLAS, H, ROBBINS, K, OLIVEIRA, J, LEWENSOHN, R, SCHÜLLER, J

Volltext

Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon C... von Schrijvers, D, Johnson, J, Jiminez, U, Gore, M, Kosmidis, P, Szpirglas, H, Robbins, K, Oliveira, J, Lewensohn, R, Schüller, J, Riviere, A, Arvay, C, Langecker, P, Jacob, H, Cvitkovic, E, Vokes, E

Volltext

A phase I trial of SU5416 a novel angiogenesis inhibitor in solid tumours, incorporating MRI assessment of vascular permeability von O'Donnell, A., Trigo, J., Walker, R., Etterley, L., Wolf, L., Raynaud, F., Padhani, A., Hannah, A., Langecker, P., Judson, I.

Volltext

Potency And Specificity Of CGS-16949A As An Aromatase Inhibitor von Santen, R. J., Langecker, P., Santner, S. J., Sikka, S., Rajfer, J., Swerdloff, R.

Volltext

Antibodies to lipoid A in the treatment of septic shock von Jaspers, L, Marget, W, Mar, P J, Hoffmann, K, Langecker, P, Ruckdeschel, G, Obermeier, A, Kastenbauer, E

Volltext

Antibody to lipoid A in the treatment of septic shock von Jaspers, L, Marget, W, Mar, P J, Hoffmann, K, Langecker, P, Ruckdeschel, G, Obermeier, A, Kastenbauer, E

Volltext

Lipid A antibodies in the treatment of septic shock von Jaspers, L, Marget, W, Mar, P J, Hoffmann, K, Langecker, P, Ruckdeschel, G, Obermeier, A, Kastenbauer, E

Volltext

Antikörper gegen Lipoid A in der Behandlung des septischen Schocks von JASPERS, L, MARGET, W, MAR, P. J, HOFFMANN, K, LANGECKER, P, RUCKDESCHEL, G, OBERMEIER, A, KASTENBAUER, E

Volltext

Antikörper gegen Lipoid A in der Behandlung des septischen Schocks von Jaspers, L., Marget, W., Mar, P. J., Hoffmann, K., Langecker, P., Ruckdeschel, G., Obermeier, A., Kastenbauer, E.

Volltext

Antibodies to lipoid A in the treatment of septic shock von Jaspers, L, Marget, W, Mar, P J, Hoffmann, K, Langecker, P, Ruckdeschel, G, Obermeier, A, Kastenbauer, E

Volltext

Antibody to lipoid A in the treatment of septic shock von Jaspers, L, Marget, W, Mar, P J, Hoffmann, K, Langecker, P, Ruckdeschel, G, Obermeier, A, Kastenbauer, E

Volltext